Skip to main content
SpringerLink
Log in

Type 3c Diabetes

  • Chapter
  • First Online:
Diabetes Management in Hospitalized Patients

Part of the book series: Contemporary Endocrinology ((COE))

  • 249 Accesses

Abstract

Type 3c diabetes, also known as pancreatogenic diabetes, is a form of secondary diabetes which occurs when primary pancreatic disorders damage the pancreatic islets of Langerhans leading to endocrine pancreatic dysfunction. Type 3c is often misdiagnosed as Type 2 diabetes (or Type 1 diabetes); however, it is remarkably different in cause, clinical presentation, treatment, and prognosis. Furthermore, patients with type 3c diabetes are more prone to experience complications and death related to hypoglycemic events. This chapter describes the epidemiology, clinical manifestations, approach to diagnosis, and treatment of pancreatogenic diabetes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Petrov MS, Basina M. DIAGNOSIS OF ENDOCRINE DISEASE: diagnosing and classifying diabetes in diseases of the exocrine pancreas. Eur J Endocrinol. 2021;184(4):R151–63.

    Article  CAS  PubMed  Google Scholar 

  2. Dite P, Bojkova M, Belobradkova J, Zak P, Kianicka B. Chronic pancreatitis and diabetes of exocrine pancreas/type 3c diabetes mellitus/post-pancreatitis diabetes mellitus. J Gastrointest Liver Dis JGLD. 2022;31(4):371–4.

    Article  Google Scholar 

  3. Ewald N, Kaufmann C, Raspe A, Kloer HU, Bretzel RG, Hardt PD. Prevalence of diabetes mellitus secondary to pancreatic diseases (type 3c). Diabetes Metab Res Rev. 2012;28(4):338–42.

    Article  CAS  PubMed  Google Scholar 

  4. Hart PA, Bellin MD, Andersen DK, Bradley D, Cruz-Monserrate Z, Forsmark CE, et al. Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer. Lancet Gastroenterol Hepatol. 2016;1(3):226–37.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Roy A, Sahoo J, Kamalanathan S, Naik D, Mohan P, Kalayarasan R. Diabetes and pancreatic cancer: exploring the two-way traffic. World J Gastroenterol. 2021;27(30):4939–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. American Diabetes Association Professional Practice Committee. 2. Classification and diagnosis of diabetes: standards of medical Care in Diabetes-2022. Diabetes Care. 2022;45(Suppl 1):S17–38.

    Google Scholar 

  7. Wei Q, Qi L, Lin H, Liu D, Zhu X, Dai Y, et al. Pathological mechanisms in diabetes of the exocrine pancreas: what’s known and What’s to know. Front Physiol. 2020;11:570276.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Kayani K, Mohammed R, Mohiaddin H. Cystic fibrosis-related diabetes. Front Endocrinol. 2018;9:20.

    Article  Google Scholar 

  9. Moran A, Pillay K, Becker D, Granados A, Hameed S, Acerini CL. ISPAD clinical practice consensus guidelines 2018: management of cystic fibrosis-related diabetes in children and adolescents. Pediatr Diabetes. 2018;19(Suppl 27):64–74.

    Article  PubMed  Google Scholar 

  10. Rickels LG and Michael R. Pancreatogenic (type 3c) diabetes. Pancreapedia exocrine pancreas knowl base [Internet]. 2015 Jan 9 [cited 2023 Apr 25]. https://pancreapedia.org/reviews/pancreatogenic-type-3c-diabetes

  11. Ewald N, Hardt PD. Diagnosis and treatment of diabetes mellitus in chronic pancreatitis. World J Gastroenterol. 2013;19(42):7276–81.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Vonderau JS, Desai CS. Type 3c: understanding pancreatogenic diabetes. JAAPA. 2022;35(11):20–4.

    Article  PubMed  Google Scholar 

  13. Maxwell DW, Jajja MR, Galindo RJ, Zhang C, Nadeem SO, Sweeney JF, et al. Post-pancreatectomy diabetes index: a validated score predicting diabetes development after major pancreatectomy. J Am Coll Surg. 2020;230(4):393–402.e3.

    Article  PubMed  Google Scholar 

  14. Chan CL, Ode KL, Granados A, Moheet A, Moran A, Hameed S. Continuous glucose monitoring in cystic fibrosis—a practical guide. J Cyst Fibros Off J Eur Cyst Fibros Soc. 2019;18(Suppl 2):S25–31.

    Article  CAS  Google Scholar 

  15. Ruxer J, Mozdzan M, Loba J, Barański M, Ruxer M, Markuszewski L. Usefulness of continuous glucose monitoring system in detection of hypoglycaemic episodes in patients with diabetes in course of chronic pancreatitis. Pol Arch Med Wewn. 2005;114(4):953–7.

    PubMed  Google Scholar 

  16. Duggan SN, Ewald N, Kelleher L, Griffin O, Gibney J, Conlon KC. The nutritional management of type 3c (pancreatogenic) diabetes in chronic pancreatitis. Eur J Clin Nutr. 2017;71(1):3–8.

    Article  CAS  PubMed  Google Scholar 

  17. Duggan S. Pancreatogenic type 3c diabetes (T3cDM): underestimated, underappreciated, and poorly managed. Pract Gastroenterol. 2017:14–23.

    Google Scholar 

  18. McCoy RG, Van Houten HK, Ziegenfuss JY, Shah ND, Wermers RA, Smith SA. Increased mortality of patients with diabetes reporting severe hypoglycemia. Diabetes Care. 2012;35(9):1897–901.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Cruz P. Inpatient hypoglycemia: the challenge remains. J Diabetes Sci Technol. 2020;14(3):560–6.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Scott ES, Fulcher GR, Clifton-Bligh RJ. Sensor-augmented CSII therapy with predictive low-glucose suspend following total pancreatectomy. Endocrinol Diabetes Metab Case Rep. 2017;2017:17–0093.

    PubMed  PubMed Central  Google Scholar 

  21. Scully KJ, Palani G, Zheng H, Moheet A, Putman MS. The effect of control IQ hybrid closed loop technology on glycemic control in adolescents and adults with cystic fibrosis-related diabetes. Diabetes Technol Ther. 2022;24(6):446–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Rickels MR, Robertson RP. Pancreatic islet transplantation in humans: recent progress and future directions. Endocr Rev. 2019;40(2):631–68.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Stony Brook Medicine, Stony Brook, NY, USA

    Marina M. Charitou

  2. Stony Brook Medicine, Stony Brook, NY, USA

    Huda Al-Bahadili

  3. Washington University, St. Louis, MO, USA

    Huda Al-Bahadili

Authors
  1. Marina M. Charitou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Huda Al-Bahadili
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marina M. Charitou .

Editor information

Editors and Affiliations

  1. Division of Endocrinology, Long Island Jewish Medical Center, Northwell Health, New Hyde Park, NY, USA

    Rifka C. Schulman-Rosenbaum

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Charitou, M.M., Al-Bahadili, H. (2023). Type 3c Diabetes. In: Schulman-Rosenbaum, R.C. (eds) Diabetes Management in Hospitalized Patients. Contemporary Endocrinology. Springer, Cham. https://doi.org/10.1007/978-3-031-44648-1_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-44648-1_15

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-44647-4

  • Online ISBN: 978-3-031-44648-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation